We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.48B
AUM Growth
+$152M
Cap. Flow
+$58.2M
Cap. Flow %
2.35%
Top 10 Hldgs %
26.38%
Holding
291
New
33
Increased
134
Reduced
93
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 24.68%
2 Technology 21.94%
3 Industrials 17.48%
4 Consumer Discretionary 13.63%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLDN icon
51
Willdan Group
WLDN
$1.27B
$15.1M 0.61%
592,106
+55,068
+10% +$1.48M
AGM icon
52
Federal Agricultural Mortgage
AGM
$2.55B
$13.9M 0.56%
217,676
+34,184
+19% +$2.21M
FATE icon
53
Fate Therapeutics
FATE
$323M
$13.1M 0.53%
+326,844
New +$11.4M
LKQ icon
54
LKQ Corp
LKQ
$6.2B
$12.7M 0.51%
459,695
+43,370
+10% +$1.28M
CSGP icon
55
CoStar Group
CSGP
$12.5B
$12.2M 0.49%
143,210
+17,680
+14% +$1.41M
TTD icon
56
Trade Desk
TTD
$6.1B
$11.9M 0.48%
229,870
-616,450
-73% -$28.2M
SWI
57
DELISTED
SolarWinds Corporation Common Stock
SWI
$11.8M 0.48%
550,120
+78,129
+17% +$1.59M
ACAD icon
58
Acadia Pharmaceuticals
ACAD
$5.06B
$11.3M 0.46%
274,979
+83,021
+43% +$3.59M
CATM
59
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$10.9M 0.44%
548,121
+486,643
+792% +$10.6M
ZGNX
60
DELISTED
Zogenix, Inc.
ZGNX
$10M 0.4%
560,182
+67,950
+14% +$1.66M
CNTY icon
61
Century Casinos
CNTY
$34M
$9.84M 0.4%
1,795,436
+194,905
+12% +$1.01M
NKTR icon
62
Nektar Therapeutics
NKTR
$2.54B
$9.84M 0.4%
39,529
+1,807
+5% +$568K
PEGA icon
63
Pegasystems
PEGA
$5.44B
$9.8M 0.4%
162,012
-72,028
-31% -$4.14M
AAP icon
64
Advance Auto Parts
AAP
$3.37B
$9.2M 0.37%
59,956
+7,389
+14% +$1.11M
PCOM
65
DELISTED
Points.com Inc. Common Shares
PCOM
$8.16M 0.33%
843,092
+162,703
+24% +$1.64M
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$16.8B
$8.12M 0.33%
56,946
+20,993
+58% +$2.6M
CDNA icon
67
CareDx
CDNA
$2.47B
$8.09M 0.33%
213,226
-77,486
-27% -$2.62M
UTMD icon
68
Utah Medical Products
UTMD
$229M
$7.94M 0.32%
99,447
+27,163
+38% +$2.25M
LOPE icon
69
Grand Canyon Education
LOPE
$3.9B
$7.83M 0.32%
97,963
+3,765
+4% +$341K
ATSG
70
DELISTED
Air Transport Services Group
ATSG
$7.76M 0.31%
309,664
-127,269
-29% -$3.18M
EPAM icon
71
EPAM Systems
EPAM
$5.04B
$7.59M 0.31%
23,484
-13,697
-37% -$4.09M
MSM icon
72
MSC Industrial Direct
MSM
$6.84B
$7.46M 0.3%
117,972
+5,357
+5% +$355K
MODN
73
DELISTED
MODEL N, INC.
MODN
$7.35M 0.3%
208,266
-77,168
-27% -$2.92M
PTC icon
74
PTC
PTC
$16.6B
$7.15M 0.29%
+86,419
New +$7.36M
NBIX icon
75
Neurocrine Biosciences
NBIX
$16.7B
$7.13M 0.29%
74,180
+9,140
+14% +$1.06M

Similar funds

Rice Hall James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Rice Hall James & Associates held 291 positions worth $2.48B, up 6.5% from $2.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2020 filing shows 33 new, 134 increased, 93 reduced and 18 closed positions. Its largest new stake was Fate Therapeutics: 326,844 shares worth $13.1M. The largest sale was Trade Desk, an estimated $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2020 buy was Fate Therapeutics: 326,844 shares worth $13.1M.
  • Rice Hall James & Associates added most to Ziff Davis in Q3 2020, an estimated $32.7M increase.
  • Rice Hall James & Associates's biggest Q3 2020 reduction was Trade Desk, cutting an estimated $28.2M.
  • Rice Hall James & Associates fully exited Aerojet Rocketdyne Holdings in Q3 2020, selling an estimated $8.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $2.48B portfolio in Q3 2020.
  • Rice Hall James & Associates opened 33 new positions and closed 18 in Q3 2020.
  • Rice Hall James & Associates's portfolio value rose 6.5% quarter-over-quarter to $2.48B.

Based on Rice Hall James & Associates's 13F filing for Q3 2020, filed 16 Nov 2020.